Search

everythinglearnresearchcommunity

for

Search:↓

Using electronic health records can help identify drug side effects but has some limitations.

A woman got a skin rash from taking aceclofenac, which went away after she stopped the drug.

The boy's hair loss was caused by the tuberculosis drug isoniazid but grew back after stopping the medication.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Finasteride-loaded nanogels are effective, safe, and improve drug absorption through the skin.

Ketoconazole loaded solid lipid nanoparticles can penetrate skin better than regular drug suspension and marketed product, providing slow, sustained release and improved stability.

Methylphenidate can cause hair loss, which stops when the drug is discontinued.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

Smart hydrogel dressings could improve diabetic wound healing by adjusting to wound conditions and controlling drug release.

Minoxidil can be effectively encapsulated in coated nanovesicles for potential drug delivery.

The 39th Manfred Donike Workshop discussed methods for detecting misuse of steroids, gene doping, and the complexity of identifying drug residues in urine, highlighting the ongoing efforts to improve global anti-doping work.

Both a lock of hair and a single hair strand can show chronic drug use, but at least six single hairs are needed for accurate results.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

The method accurately measures the amount of ketoconazole in anti-dandruff shampoo and cream, and can also be used to monitor the drug in human plasma.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

A new liposomal formulation improves drug delivery and hair growth for treating hair loss without causing skin irritation.

The research identified genes linked to male-pattern baldness and potential drug targets for treatment.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Most pediatric inpatients needed dermatology consultations for unspecified rashes and drug reactions, with varied treatments.

Some hair loss from medication may reverse after stopping the drug, but treatment options are limited and ongoing research is needed.

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

Finasteride may cause gum problems, but stopping the drug can improve these issues.

The document concludes that proper diagnosis and treatment of follicular disorders are crucial, with specific treatments for conditions like acne, drug-induced eruptions, and rosacea.

Dr. Jia-You Fang is a highly experienced researcher in drug delivery and related fields, with numerous publications and international collaborations.

Hair analysis can be unreliable due to external contamination and varying drug concentrations.

Understanding drug effects and careful monitoring are crucial for safe and effective dermatology treatments.

Finasteride-coated microneedles effectively deliver the drug with minimal scalp damage and high stability.

Hair follicles help absorb and store topical compounds, aiding targeted drug delivery.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.